Musa V Mabandla Selected Research

Febrile Seizures (Febrile Seizure)

7/2020	Glutamatergic pathway in depressive-like behavior associated with pentylenetetrazole rat model of epilepsy with history of prolonged febrile seizures.
1/2020	Prolonged febrile seizure history exacerbates seizure severity in a pentylenetetrazole rat model of epilepsy.
10/2019	Upregulation of hippocampal synaptophysin, GFAP and mGluR3 in a pilocarpine rat model of epilepsy with history of prolonged febrile seizure.
1/2019	Transgenerational deep sequencing revealed hypermethylation of hippocampal mGluR1 gene with altered mRNA expression of mGluR5 and mGluR3 associated with behavioral changes in Sprague Dawley rats with history of prolonged febrile seizure.
1/2019	Acetylcholine receptor agonist effect on seizure activity and GABAergic mechanisms involved in prolonged febrile seizure development in an animal model.
2/2016	Searsia chirindensis reverses the potentiating effect of prenatal stress on the development of febrile seizures and decreased plasma interleukin-1β levels.
11/2015	Prenatal stress and early life febrile convulsions compromise hippocampal genes MeCP2/REST function in mid-adolescent life of Sprague-Dawley rats.
10/2015	Exposure to prenatal stress has deleterious effects on hippocampal function in a febrile seizure rat model.
9/2012	Exposure to prenatal stress enhances the development of seizures in young rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Musa V Mabandla Research Topics

Disease

9	Febrile Seizures (Febrile Seizure) 07/2020 - 09/2012
7	Parkinson Disease (Parkinson's Disease) 01/2020 - 12/2005
3	Epilepsy (Aura) 07/2020 - 10/2019
3	Cognitive Dysfunction 01/2020 - 01/2017
3	Neuroinflammatory Diseases 01/2020 - 12/2018
2	Prediabetic State (Prediabetes) 04/2021 - 01/2020
2	Parkinsonian Disorders (Parkinsonism) 01/2020 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2020
2	Malaria 07/2017 - 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2021
1	Body Weight Changes 04/2021
1	Necrosis 04/2021
1	Dementia (Dementias) 01/2020
1	Temporal Lobe Epilepsy 10/2019
1	Gliosis 12/2018
1	Nervous System Diseases (Neurological Disorders) 11/2018
1	Infections 07/2017
1	Anhedonia 01/2017
1	Substance-Related Disorders (Drug Abuse) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Anxiety Disorders (Anxiety Disorder) 10/2016
1	Dyskinesias (Dyskinesia) 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2005

Drug/Important Bio-Agent (IBA)

4	Fluvoxamine (Luvox)FDA LinkGeneric 01/2020 - 10/2016
4	CytokinesIBA 01/2020 - 09/2012
4	Oxidopamine (6 Hydroxydopamine)IBA 01/2020 - 12/2009
3	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 12/2005
3	metabotropic glutamate receptor 3 (mGluR3)IBA 01/2020 - 01/2019
3	Kainic Acid (Kainate)IBA 01/2019 - 10/2015
3	LipopolysaccharidesIBA 01/2019 - 10/2015
2	Blood Glucose (Blood Sugar)IBA 04/2021 - 01/2016
2	CarbohydratesIBA 04/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2020
2	Glutamic Acid (Glutamate)FDA Link 07/2020 - 01/2019
2	Pentylenetetrazole (Metrazol)IBA 07/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2019
2	SynaptophysinIBA 01/2020 - 10/2019
2	Amyloid beta-PeptidesIBA 01/2020 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2020
2	Neuroprotective AgentsIBA 01/2019 - 12/2005
2	Oleanolic AcidIBA 01/2016 - 01/2016
1	Triglycerides (Triacylglycerol)IBA 04/2021
1	CholesterolIBA 04/2021
1	C-Reactive ProteinIBA 04/2021
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2021
1	Glutathione PeroxidaseIBA 04/2021
1	Malondialdehyde (Propanedial)IBA 04/2021
1	Glutamate SynthaseIBA 07/2020
1	Carrier Proteins (Binding Protein)IBA 07/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2020
1	Cocaine (Cocaine HCl)IBA 12/2019
1	Pharmaceutical PreparationsIBA 12/2019
1	Pilocarpine (Ocusert)FDA LinkGeneric 10/2019
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	metabotropic glutamate receptor type 1IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Cholinergic ReceptorsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Nevirapine (Viramune)FDA Link 12/2018
1	Tenofovir (Viread)FDA Link 12/2018
1	Antidepressive Agents (Antidepressants)IBA 01/2018
1	Antimalarials (Antimalarial Agents)IBA 07/2017
1	PectinsIBA 07/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Histone Deacetylase InhibitorsIBA 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	Sucrose (Saccharose)IBA 01/2017
1	LipidsIBA 02/2016
1	Dihydroxyphenylalanine (Dopa)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Levodopa (L Dopa)FDA LinkGeneric 01/2016
1	Chloroquine (Aralen)FDA LinkGeneric 01/2016
1	AcidsIBA 01/2016
1	Interleukin-1beta (Interleukin 1 beta)IBA 09/2012

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2019
1	Highly Active Antiretroviral Therapy (HAART) 11/2018
1	Therapeutics 01/2016
1	Injections 11/2015